LONGMONT, Colo. — KromaTiD, Inc. today announced the appointment of Vic Myer to its Board of Directors. Dr. Myer joins KromaTiD’s Board with extensive experience in technology, R&D and pharmaceutical company executive leadership, including 5 years of experience as Chief Technology Officer of Editas Medicine, a leading developer of gene editing-based therapies. He is currently Entrepreneur in Residence […]
Total RNA is comprised of large amounts of undesired transcripts, such as ribosomal RNA (rRNA), which account for ~80-98 % of the total RNA sample, and globin mRNA, accounting for ~35-80 % of mRNA in blood samples. Therefore, RNA sample preparation for sequencings requires stringent rRNA and (for blood samples) globin depletion. The upgraded version […]
• Transaction strengthens QIAGEN’s leadership position in automated molecular testing • QIAGEN acquires remaining 80.1% stake in NeuMoDx Molecular, Inc. for $248 million • Medium- and high-throughput NeuMoDx automation solutions based on PCR testing technology to now be integrated into QIAGEN’s portfolio on a global basis • Menu of test solutions for infectious diseases – […]
Financing to support commercial launch of multiple “Powered by Cardea” product collaborations under the Cardea Innovation Partnership Program and accelerated growth of the Tech+Bio Infrastructure. SAN DIEGO — Cardea Bio Inc., who is integrating tiny bits of biology into modern electronics, via their Graphene-based Biology-gated Transistors (“Cardean Transistors™”), just announced the first closing in their […]
The new AutoGen vortex module upgrade enables a 35% improvement in throughput Holliston, MA: AutoGen Inc. is excited to announce the launch of the vortex module upgrade to their portfolio of FlexSTAR workflows. FlexSTAR workflows are fully automated instruments for isolating genomic DNA from large volumes of whole blood, buffy coats, saliva, cultured cells, and […]
CANCERPREV Cross-Disciplinary Program Expands Knowledge of Cancer Development to Deliver New Insights into Prevention Strategies Principal Focus on Advancing Understanding of Breast and Skin Cancer Risks SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced its participation in CANCERPREV, a research […]
New Cas9 Sequencing Kit provides reagents for one-stop targeted sequencing, enabling scientists to cost-effectively sequence previously inaccessible target regions. Cas9 targeted sequencing with nanopore enables fast, simple, flexible target enrichment of long regions of interest – read lengths of over 100 kb have been observed to date. The approach is amplification-free, opening up regions of the genome previously […]
Streamlines the sample submission process for hybridoma sequencing customers Redcar, UK. Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the availability of the SeqPack™ Hybridoma Preservation Kit, which streamlines the sample submission process for hybridoma sequencing customers worldwide. The kit saves customers both time and money by eliminating the need […]
DUBLIN, Ireland, and Milpitas, CA USA: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced it has signed an agreement with Applied StemCell, Inc., a leading provider of stem cell, animal model, antibody discovery services and reagents. ERS Genomics holds […]
The SMRTbell gDNA Sample Amplification Kit enables whole genome amplification starting from as little as 5 ng of genomic DNA. It’s one of the questions we hear most often from scientists working with small organisms: Is it possible to generate truly high-quality, long-read data from minuscule amounts of DNA? With our new kit for ultra-low […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
